An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients

Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays...

Full description

Bibliographic Details
Main Authors: Florian Scheichel, Daniel Pinggera, Branko Popadic, Camillo Sherif, Franz Marhold, Christian Franz Freyschlag
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.884724/full
_version_ 1818018766522417152
author Florian Scheichel
Florian Scheichel
Daniel Pinggera
Branko Popadic
Branko Popadic
Camillo Sherif
Camillo Sherif
Franz Marhold
Franz Marhold
Christian Franz Freyschlag
author_facet Florian Scheichel
Florian Scheichel
Daniel Pinggera
Branko Popadic
Branko Popadic
Camillo Sherif
Camillo Sherif
Franz Marhold
Franz Marhold
Christian Franz Freyschlag
author_sort Florian Scheichel
collection DOAJ
description Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients.
first_indexed 2024-04-14T07:44:06Z
format Article
id doaj.art-493efeaad0a94aa8a624fa105ce3b6db
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-14T07:44:06Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-493efeaad0a94aa8a624fa105ce3b6db2022-12-22T02:05:24ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.884724884724An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent PatientsFlorian Scheichel0Florian Scheichel1Daniel Pinggera2Branko Popadic3Branko Popadic4Camillo Sherif5Camillo Sherif6Franz Marhold7Franz Marhold8Christian Franz Freyschlag9Karl Landsteiner University of Health Sciences, Krems, AustriaDepartment of Neurosurgery, University Hospital St. Poelten, St. Poelten, AustriaDepartment of Neurosurgery, Medical University of Innsbruck, Innsbruck, AustriaKarl Landsteiner University of Health Sciences, Krems, AustriaDepartment of Neurosurgery, University Hospital St. Poelten, St. Poelten, AustriaKarl Landsteiner University of Health Sciences, Krems, AustriaDepartment of Neurosurgery, University Hospital St. Poelten, St. Poelten, AustriaKarl Landsteiner University of Health Sciences, Krems, AustriaDepartment of Neurosurgery, University Hospital St. Poelten, St. Poelten, AustriaDepartment of Neurosurgery, Medical University of Innsbruck, Innsbruck, AustriaPrimary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients.https://www.frontiersin.org/articles/10.3389/fonc.2022.884724/fullPrimary central nervous system lymphoma (PCNSL)corticosteroid therapydiagnostic workupdiagnostic delaydiagnostic yield
spellingShingle Florian Scheichel
Florian Scheichel
Daniel Pinggera
Branko Popadic
Branko Popadic
Camillo Sherif
Camillo Sherif
Franz Marhold
Franz Marhold
Christian Franz Freyschlag
An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
Frontiers in Oncology
Primary central nervous system lymphoma (PCNSL)
corticosteroid therapy
diagnostic workup
diagnostic delay
diagnostic yield
title An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_full An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_fullStr An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_full_unstemmed An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_short An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_sort update on neurosurgical management of primary cns lymphoma in immunocompetent patients
topic Primary central nervous system lymphoma (PCNSL)
corticosteroid therapy
diagnostic workup
diagnostic delay
diagnostic yield
url https://www.frontiersin.org/articles/10.3389/fonc.2022.884724/full
work_keys_str_mv AT florianscheichel anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT florianscheichel anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT danielpinggera anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT brankopopadic anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT brankopopadic anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT camillosherif anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT camillosherif anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT franzmarhold anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT franzmarhold anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT christianfranzfreyschlag anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT florianscheichel updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT florianscheichel updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT danielpinggera updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT brankopopadic updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT brankopopadic updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT camillosherif updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT camillosherif updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT franzmarhold updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT franzmarhold updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT christianfranzfreyschlag updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients